Microbix Biosystems (MBX) News Today C$0.30 0.00 (0.00%) As of 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesBuy This Stock MBX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period What is Bloom Burton's Forecast for TSE:MBX FY2025 Earnings?June 10 at 1:22 AM | americanbankingnews.comMicrobix Reports Results for Q2 Fiscal 2025May 15, 2025 | financialpost.comMicrobix Reports Results for Q2 Fiscal 2025May 15, 2025 | financialpost.comMicrobix & Aurevia Introduce Novel EQA SchemeMay 13, 2025 | finance.yahoo.comMicrobix Schedules Release of Results for Q2 Fiscal 2025May 8, 2025 | finance.yahoo.comMicrobix Advances Kinlytic Urokinase Production with New CDMO AgreementMay 5, 2025 | tipranks.comMicrobix to Present at 2025 Bloom Burton Healthcare Investor ConferenceMay 1, 2025 | tipranks.comMicrobix Presenting at the 2025 Bloom Burton ConferenceMay 1, 2025 | financialpost.comMicrobix Biosystems Inc.'s (TSE:MBX) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?April 30, 2025 | finance.yahoo.comMicrobix to Showcase Diagnostic Innovations at ESCMID Global 2025April 9, 2025 | tipranks.comMicrobix Exhibiting at ESCMID Global 2025April 9, 2025 | financialpost.comMicrobix Provides Business UpdatesApril 8, 2025 | markets.businessinsider.comMicrobix Biosystems Navigates Tariff Challenges with Strategic GrowthApril 8, 2025 | tipranks.comMicrobix Biosystems Inc.: Microbix Announces Annual and Special Meeting Voting ResultsMarch 28, 2025 | finanznachrichten.deMicrobix Biosystems Inc.: Microbix Further Optimizes Capital Usage and AvailabilityMarch 26, 2025 | finanznachrichten.deMicrobix Further Optimizes Capital Usage and AvailabilityMarch 26, 2025 | finance.yahoo.comMicrobix Optimizes Capital Structure for Greater Financial FlexibilityMarch 26, 2025 | tipranks.comMicrobix Biosystems: Top 10 Undervalued Biotechnology Industry Stocks (MBX)March 24, 2025 | theglobeandmail.comMicrobix Partners with ACPCC to Combat Cervical Cancer in Indo-PacificMarch 17, 2025 | tipranks.comMicrobix & ACPCC support efforts to eliminate cervical cancer in the Indo-PacificMarch 17, 2025 | finance.yahoo.comMicrobix Biosystems Inc. (TSE:MBX) Senior Officer Sells C$30,295.15 in StockMarch 4, 2025 | insidertrades.comMark Adrian Luscher Sells 70,750 Shares of Microbix Biosystems Inc. (TSE:MBX) StockMicrobix Biosystems Inc. (TSE:MBX - Get Free Report) Senior Officer Mark Adrian Luscher sold 70,750 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of C$0.43, for a total transaction of C$30,295.15.March 3, 2025 | marketbeat.comMicrobix Hosts Ontario Premier, Showcases Innovations in Life SciencesFebruary 27, 2025 | tipranks.comMicrobix Biosystems (TSE:MBX) Stock Crosses Above 50 Day Moving Average - Here's WhyMicrobix Biosystems (TSE:MBX) Shares Cross Above Fifty Day Moving Average - Time to Sell?February 26, 2025 | marketbeat.comMicrobix Presenting at Investor Conference in B.C.February 19, 2025 | markets.businessinsider.comMicrobix Engages Investors at Whistler Capital Event 2025February 19, 2025 | tipranks.comMicrobix Biosystems (TSE:MBX) Stock Price Crosses Above 50-Day Moving Average - Time to Sell?Microbix Biosystems (TSE:MBX) Share Price Passes Above 50-Day Moving Average - Time to Sell?February 18, 2025 | marketbeat.comMicrobix Biosystems (TSE:MBX) Hits New 52-Week High - Still a Buy?Microbix Biosystems (TSE:MBX) Hits New 52-Week High - Here's WhyFebruary 15, 2025 | marketbeat.comMicrobix projects 20-40% revenue growth for fiscal 2025 amid new market expansionsFebruary 14, 2025 | msn.comMicrobix Reports Strong Revenues & Earnings for Q1 Fiscal 2025February 14, 2025 | markets.businessinsider.comMicrobix Biosystems Inc.: Microbix Reports Strong Revenues & Earnings for Q1 Fiscal 2025February 13, 2025 | finanznachrichten.deMicrobix Biosystems (TSE:MBX) Shares Pass Above Fifty Day Moving Average - Should You Sell?Microbix Biosystems (TSE:MBX) Shares Pass Above Fifty Day Moving Average - Here's What HappenedFebruary 8, 2025 | marketbeat.comMicrobix Schedules Release of Results for Q1 Fiscal 2025February 6, 2025 | markets.businessinsider.comMicrobix Receives $2.4 Million from Exercise of WarrantsFebruary 4, 2025 | finance.yahoo.comMicrobix Strengthens Financial Position with C$ 2.4 Million Equity CapitalFebruary 4, 2025 | tipranks.comInsider Selling: Microbix Biosystems Inc. (TSE:MBX) Director Sells 150,000 Shares of StockJanuary 31, 2025 | insidertrades.comMicrobix Biosystems Inc. (TSE:MBX) Director Sells C$73,500.00 in StockMicrobix Biosystems Inc. (TSE:MBX - Get Free Report) Director Bo Hollas sold 150,000 shares of the company's stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of C$0.49, for a total transaction of C$73,500.00.January 30, 2025 | marketbeat.comMicrobix Biosystems (TSE:MBX) Shares Down 3.8% After Insider SellingMicrobix Biosystems (TSE:MBX) Trading Down 3.8% on Insider SellingJanuary 23, 2025 | marketbeat.comCameron Lionel Groome Sells 200,000 Shares of Microbix Biosystems Inc. (TSE:MBX) StockMicrobix Biosystems Inc. (TSE:MBX - Get Free Report) Director Cameron Lionel Groome sold 200,000 shares of Microbix Biosystems stock in a transaction that occurred on Wednesday, January 22nd. The shares were sold at an average price of C$0.43, for a total value of C$86,500.00.January 23, 2025 | marketbeat.comMicrobix Biosystems Inc. (TSE:MBX) Senior Officer Philip Jonathan Casselli Sells 50,000 SharesJanuary 23, 2025 | insidertrades.comMicrobix Biosystems Inc. (TSE:MBX) Senior Officer Sells C$21,000.00 in StockMicrobix Biosystems Inc. (TSE:MBX - Get Free Report) Senior Officer Philip Jonathan Casselli sold 50,000 shares of Microbix Biosystems stock in a transaction that occurred on Wednesday, January 22nd. The shares were sold at an average price of C$0.42, for a total transaction of C$21,000.00.January 22, 2025 | marketbeat.comMicrobix Biosystems (TSE:MBX) Reaches New 1-Year High - Here's WhyMicrobix Biosystems (TSE:MBX) Reaches New 1-Year High - Should You Buy?January 22, 2025 | marketbeat.comMicrobix Biosystems (TSE:MBX) Stock Passes Above 50-Day Moving Average - Here's What HappenedMicrobix Biosystems (TSE:MBX) Stock Crosses Above 50 Day Moving Average - What's Next?January 21, 2025 | marketbeat.comMicrobix & API Ensuring Flu Tests Can Detect H5N1 StrainJanuary 13, 2025 | markets.businessinsider.comMicrobix Expanding Addressable Market Share with Test Makers Augmenting its Recombinant Antigen Capabilities for Immunoassay MarketsJanuary 8, 2025 | markets.businessinsider.comMicrobix Biosystems: Strong Q4 Performance and Promising Growth ProspectsDecember 22, 2024 | markets.businessinsider.comMicrobix Biosystems Inc.: Microbix Reports Record Product Sales for Q4 and Fiscal 2024December 19, 2024 | finanznachrichten.deMicrobix Biosystems Reports Record Revenue GrowthDecember 19, 2024 | tipranks.comMicrobix Reports Record Product Sales for Q4 and Fiscal 2024December 19, 2024 | financialpost.comMicrobix Schedules Release of Results for Q4 Fiscal 2024December 12, 2024 | markets.businessinsider.com Get Microbix Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Email Address MBX Media Mentions By Week MBX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MBX News Sentiment▼-1.000.68▲Average Medical News Sentiment MBX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MBX Articles This Week▼41▲MBX Articles Average Week Get Microbix Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Theratechnologies News Today Aptose Biosciences News Today Medicenna Therapeutics News Today Covalon Technologies News Today Sernova News Today Helix BioPharma News Today Oncolytics Biotech News Today Devonian Health Group News Today Sirona Biochem News Today Hemostemix News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:MBX) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbix Biosystems Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbix Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.